Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01445873
What this trial is testing

Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 36
Not applicableStudy completedNCT03069716
What this trial is testing

A Mobile Health Intervention in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial Hypertension+1 more
Vanderbilt University Medical Center 49
Not applicableWithdrawnNCT04559516
What this trial is testing

Remote Exercise Program Delivery Using a Mobile Application for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
University of Calgary
Not applicableUnknownNCT04053296
What this trial is testing

Long-term Outcomes of Pregnant Women With PAH

Who this might be right for
Pulmonary Arterial Hypertension
RenJi Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06351345
What this trial is testing

129 Xenon Imaging in Patients Treated With Sotatercept

Who this might be right for
Pulmonary HypertensionPulmonary Arterial Hypertension
Bastiaan Driehuys 14
Post-approval studies (Phase 4)Study completedNCT02705807
What this trial is testing

Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 10
Post-approval studies (Phase 4)Looking for participantsNCT07713914
What this trial is testing

Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
University of Sao Paulo General Hospital 196
Post-approval studies (Phase 4)Study completedNCT01642407
What this trial is testing

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionHypertension, Pulmonary
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT05339087
What this trial is testing

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH

Who this might be right for
Pulmonary Vascular DisorderPrimary Pulmonary HypertensionSystemic Sclerosis+1 more
Heidelberg University 35
Not applicableNot Yet RecruitingNCT07781709
What this trial is testing

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 20
Not applicableStudy completedNCT03293407
What this trial is testing

Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Bayer 31
Early research (Phase 1)Study completedNCT00800592
What this trial is testing

Sildenafil IV Bolus Study

Who this might be right for
Hypertension, Pulmonary
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 12
Testing effectiveness (Phase 2)Ended earlyNCT00832507
What this trial is testing

Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 162
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Who this might be right for
Pulmonary HypertensionPulmonary Arterial Hypertension
United Therapeutics 10
Large-scale testing (Phase 3)Ended earlyNCT05036135
What this trial is testing

AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aerovate Therapeutics 202
Not applicableEnded earlyNCT05060315
What this trial is testing

Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT01086540
What this trial is testing

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Who this might be right for
Systemic Sclerosis-Associated PAH
National Institute of Allergy and Infectious Diseases (NIAID) 57
Not applicableStudy completedNCT05339386
What this trial is testing

Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Kansas Medical Center 10
Not applicableUnknownNCT06405126
What this trial is testing

Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionHFpEF - Heart Failure With Preserved Ejection Fraction
KU Leuven 100
Early research (Phase 1)Study completedNCT04095286
What this trial is testing

Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants

Who this might be right for
Hypertension, Pulmonary
GlaxoSmithKline 29
Next Page